The WACC of Union Korea Pharm Co Ltd (080720.KQ) is 5.4%.
Range | Selected | |
Cost of equity | 6.5% - 8.7% | 7.6% |
Tax rate | 23.1% - 24.4% | 23.75% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 4.3% - 6.6% | 5.4% |
Category | Low | High |
Long-term bond rate | 3.1% | 3.6% |
Equity market risk premium | 5.8% | 6.8% |
Adjusted beta | 0.59 | 0.68 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.5% | 8.7% |
Tax rate | 23.1% | 24.4% |
Debt/Equity ratio | 1.72 | 1.72 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 4.3% | 6.6% |
Selected WACC | 5.4% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
080720.KQ | Union Korea Pharm Co Ltd | 1.11 | 0.37 | 0.2 |
002210.KS | Dongsung Pharmaceutical Co Ltd | 0.72 | -0.25 | -0.16 |
002720.KS | Kukje Pharma Co Ltd | 0.31 | 0.22 | 0.18 |
007370.KQ | Jin Yang Pharmaceutical Co Ltd | 0.99 | 0.78 | 0.44 |
009300.KQ | Sam-A Pharm Co Ltd | 0.12 | 0.05 | 0.05 |
014570.KQ | Korean Drug Co Ltd | 0 | 0.48 | 0.48 |
018680.KQ | Seoul Pharma Co Ltd | 0.43 | 0.01 | 0.01 |
041910.KQ | EstechPharma Co Ltd | 0.01 | 1.33 | 1.33 |
106190.KQ | High Tech Pharm Co Ltd | 0.06 | 0.31 | 0.29 |
200780.KQ | BCWorldPharm Co Ltd | 1.89 | 0.42 | 0.17 |
Low | High | |
Unlevered beta | 0.18 | 0.24 |
Relevered beta | 0.39 | 0.52 |
Adjusted relevered beta | 0.59 | 0.68 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 080720.KQ:
cost_of_equity (7.60%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.59) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.